Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Total Liabilities (Quarterly) : 15.29M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.29M |
| March 31, 2026 | 16.99M |
| December 31, 2025 | 18.04M |
| September 30, 2025 | 20.31M |
| June 30, 2025 | 20.29M |
| March 31, 2025 | 37.85M |
| December 31, 2024 | 34.34M |
| September 30, 2024 | 33.55M |
| June 30, 2024 | 37.59M |
| March 31, 2024 | 35.65M |
| December 31, 2023 | 38.38M |
| September 30, 2023 | 39.30M |
| June 30, 2023 | 42.13M |
| March 31, 2023 | 47.31M |
| December 31, 2022 | 58.57M |
| September 30, 2022 | 58.28M |
| June 30, 2022 | 62.69M |
| March 31, 2022 | 71.03M |
| December 31, 2021 | 35.05M |
| September 30, 2021 | 35.46M |
| June 30, 2021 | 34.55M |
| March 31, 2021 | 32.09M |
| December 31, 2020 | 35.11M |
| September 30, 2020 | 33.76M |
| June 30, 2020 | 32.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 29.36M |
| December 31, 2019 | 32.79M |
| September 30, 2019 | 33.64M |
| June 30, 2019 | 28.10M |
| March 31, 2019 | 28.01M |
| December 31, 2018 | 27.67M |
| September 30, 2018 | 30.15M |
| June 30, 2018 | 38.94M |
| March 31, 2018 | 37.61M |
| December 31, 2017 | 54.69M |
| September 30, 2017 | 72.45M |
| June 30, 2017 | 79.29M |
| March 31, 2017 | 79.04M |
| December 31, 2016 | 72.91M |
| September 30, 2016 | 98.10M |
| June 30, 2016 | 99.54M |
| March 31, 2016 | 165.18M |
| December 31, 2015 | 164.61M |
| September 30, 2015 | 168.82M |
| June 30, 2015 | 185.32M |
| March 31, 2015 | 193.37M |
| December 31, 2014 | 30.14M |
| September 30, 2014 | 29.56M |
| June 30, 2014 | 26.92M |
| March 31, 2014 | 33.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 4.20B |
| Insmed, Inc. | 1.345B |
| Pfizer Inc. | 115.64B |
| Gossamer Bio, Inc. | 170.90M |
| Legend Biotech Corp. | 521.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 274.02M |
| Shareholders Equity (Quarterly) | 258.73M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 81.42 |
| Net Debt Paydown Yield | 0.04% |